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Background/aim: Cancer patients frequently need intensive care support due to respiratory failure. We aimed to evaluate the predictors
of mortality in cancer patients who were admitted to the intensive care unit (ICU).
Materials and methods: This study was performed in the ICUs of two centers between 1 January 2008 and 31 December 2015.
Demographic data, cancer type, causes of respiratory failure, comorbidities, APACHE II scores, treatments, and mortality rates were
recorded.
Results: A total number of 583 cancer patients (477 males) were enrolled from the two centers. Of those, 472 patients had lung cancer
(81%), while 111 had extrapulmonary malignancies (19%), having similar mortality rates. Causes of respiratory failure were mostly
invasion of the cancer itself in 84% of cases and due to infection in 12%. ICU mortality rate was 53% and the 1-year mortality rate was
80%. APACHE II scores were significantly higher in nonsurvivors (P < 0.001). One-year survival was found to be significantly shorter
in females than males (9 days vs. 12 days) in patients with lung cancer.
Conclusion: Mortality rates of cancer patients who need ICU support are higher than overall ICU mortality. High APACHE II scores
and female sex seem to be related to mortality in these patients.
Key words: Intensive care unit, cancer, respiratory failure, mortality

1. Introduction
Respiratory failure requiring intensive care support
holds an important place among cancer patients. Due
to an increase in the incidence of cancer and treatment
facilities together with improvements, the number of
cancer patients is increasing in intensive care units
(ICUs). The main causes of respiratory failure in patients
with malignancies are commonly infections, pulmonary
embolism, direct tumoral involvement of the respiratory
system, cancer-related medical disorders, and anticancer
drug-induced respiratory distress (1). Accompanying
diseases such as chronic obstructive pulmonary disease
(COPD) and complications of the primary disease
requiring ICU support may also lead to respiratory failure
and cause higher mortality (2).
Today, developing techniques and intensive
care support may be life-saving in selected patients
undergoing oncologic treatment. ICU admission is costly,
so predicting cancer patients who may benefit from ICU

treatment is important, especially in developing countries.
To select patients for ICU admission, information on
factors associated with ICU mortality is required.
In this study, we aimed to evaluate the outcome and
factors affecting survival of patients with advanced lung
cancer and other cancers (breast, prostate cancer, etc.)
who were admitted to the ICU.
2. Materials and methods
This study was performed in the medical ICUs of two
teaching hospitals specializing in pulmonary diseases.
After obtaining approval from the institutional review
board, a retrospective analysis of the medical records of
cancer patients who were admitted to the two ICUs was
performed between 1 January 2008 and 31 December
2015. Patients who were treated in the ICU for less than
24 h and those admitted for routine postoperative care
were excluded from the study. For those patients who
were admitted more than once to the ICU during the
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same hospitalization, only the first ICU admission was
analyzed.
Demographic, physiological, and clinical data including
age, sex, race, smoking history, and comorbidities upon
admission to the ICU were retrieved.
The Acute Physiology and Chronic Health Evaluation
(APACHE) II score was calculated retrospectively for each
patient based on data obtained within the first 24 h after
their admission to ICU.
2.1. Statistical analysis
All patients were evaluated longitudinally to determine
their ICU and hospital outcomes. Values were reported
as medians (interquartile ranges) and compared by the
Mann–Whitney U test. All percentages were approximated
to round numbers. Nominal data were analyzed using the
chi-square test. Multiple logistic regression analysis was
used to identify the variables that were independently
associated with mortality. Each variable that was found
to be significant at P < 0.05 by univariate analysis was
introduced into a backward, stepwise, logistic regression
model. Risk estimations were expressed as odds ratios with
95% confidence intervals (OR, 95% CI). P < 0.05 was used
to indicate statistical significance.
3. Results
Between 1 January 2008 and 31 December 2015, there
were 583 admissions of patients with cancer in the two
ICUs. Of these patients, 82% were male and 18% were
female. Median age was 64 (57–71) years. Comorbidities
were reported in 71 patients. A total of 472 patients had
lung cancer, while 111 patients had extrapulmonary
cancer. Cancer invasion was the most frequent respiratory

indication for ICU admission (391 patients); the second
most common respiratory condition was pneumonia
(57 patients) and other respiratory conditions included
acute exacerbation of COPD, hemoptysis, and malignant
pleural effusions. Initially, 451 patients required invasive
mechanical ventilation (IMV), 98 patients were treated
with noninvasive ventilation, and 34 patients had only
medical or symptomatic (NIV) treatment. Median ICU
stay length was 5 (2–10) days (Table 1). One-year mortality
was 80%.
Median 1-year survival of all patients was 12 (95% CI:
10–14) days (Figure 1). One-year survival was slightly
longer in males compared to females (log-rank P: 0.07,
Figure 2). When only patients with lung cancer were
evaluated, 1-year survival was found to be significantly
shorter in females than males (log-rank P: 0.015, Figure 3)
3.1. Factors predicting ICU mortality
Of the 583 patients, 311 died in the ICU (53%) and 272
patients were discharged from ICU. In univariate analysis,
age, comorbidities, and sex did not influence ICU mortality.
Patients with lung cancer and those with extrapulmonary
cancer did not differ in terms of mortality rate. APACHE
II severity scores significantly predicted ICU mortality (P
< 0.001). A need for intubation and IMV was associated
with higher mortality rates (P < 0.001) (Table 2).
Multivariate analysis identified three factors
independently associated with higher ICU mortality:
female sex (OR: 2.07, 95% CI: 1.23–3.49, P = 0.006), need
for intubation and IMV (OR: 2.84, 95% CI: 1.73–4.68, P <
0.001), and APACHE II score (OR 1.10, 95% CI: 1.07–1.13,
P < 0.001) (Table 3).

Table 1. Demographic data of cancer patients in the ICU.
Age, median (IQR)

65 (57–72)

Males, n (%)

477 (82)

APACHE II score, median (IQR)

24 (18–30)

Existence of comorbidity, n (%)

74 (13)

Cancer type, n (%)
Pulmonary
Extrapulmonary

472 (81)
111 (19)

Cause of respiratory failure, n (%)
Invasion of the cancer
Infection
Other

391 (67)
92 (16)
100 (17)

Need for intubation and IMV, n (%)

453 (78)

APACHE: Acute Physiologic and Chronic Health Evaluation, IMV: invasive mechanical
ventilation, IQR: interquartile range.
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Figure 1. Kaplan–Meier survival of all patients.

Figure 2. Comparison of survival curves of male and female patients.

4. Discussion
A large proportion of cancer patients experience acute
life-threatening episodes related to their malignancy,
treatment, or comorbidities. Until recently, ICU admission
of patients with advanced cancer was controversial and
generally discouraged (3). However, over the last decade,
several studies found increased survival rates in this
population (4,5). Advances in both oncology and intensive
care may have contributed to improved survival rates,
along with better selection of the patients most likely to
benefit from ICU admission (6).
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We found an ICU mortality rate of 53%. These results
are in accordance with the data recently reported by
Reichner et al. (7), Rocques et al. (8), and Andréjak et al.
(9). However, our patients had more advanced disease
than those in the earlier studies, and also some of our
patients had extrapulmonary cancer (but most of them
had pulmonary cancer), suggesting that ICU mortality
rates may have improved as noticed in other recent studies.
Mortality rates in lung cancer patients admitted to the
ICU have decreased over time. In early studies, mortality
ranged from 75% to 91% (10–12). Although Adam et al.
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Figure 3. Comparison of survival curves of male and female lung cancer patients.

Table 2. Comparison of data between survivors and nonsurvivors in the ICU.
Variable

Survivors
n = 272

Nonsurvivors
n = 311

P

Age, median (IQR)

64 (57–70)

65 (57–72)

0.23

Sex, n (%)
Female
Male

42 (16)
230 (84)

64 (20)
247 (80)

0.13

Existence of comorbidity, n (%)

39 (14)

35 (11)

0.32

Cancer type, n (%)
Pulmonary
Extrapulmonary

216 (79)
56 (21)

256 (82)
55 (18)

0.39

APACHE II, median (IQR)

19 (15–25)

27 (22–32)

<0.001

Length of ICU stay, days, median (IQR)

6 (3–11)

4 (2–10)

0.01

Need for intubation and IMV, n (%)

171 (63)

282 (91)

<0.001

APACHE: Acute Physiologic and Chronic Health Evaluation, ICU: intensive care unit, IMV: invasive
mechanical ventilation, IQR: interquartile range.

(13) recently reported an ICU mortality rate of only 22%,
only 49% of their patients required mechanical ventilation
(versus 78% intubation and mechanical ventilation
requirement in our study). Moreover, the study by Adam
et al. included patients with all stages of lung cancer. In
our study, mortality was highest in the intubated and
mechanically ventilated patients, as well as in Adam et

al.’s study. Our study also included patients with locally
advanced and advanced lung cancer and extrapulmonary
cancers.
ICU mortality was not significantly influenced by age
or comorbidities in the present study. Female sex was
associated with poor survival. Andréjak et al. found that
ICU mortality was not significantly influenced by age, sex,
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Table 3. Risk factors for mortality of cancer patients in the ICU.
Variable

Odds ratio (95% CI)

P

Female sex

2.07 (1.23–3.49)

0.006

APACHE II

1.10 (1.07–1.13)

<0.001

Need for intubation and IMV

2.84 (1.73–4.68)

<0.001

CI: Confidence interval, APACHE: Acute Physiologic and Chronic Health Evaluation, ICU: intensive
care unit, IMV: invasive mechanical ventilation.

or comorbidities. A history of thoracic radiotherapy was
associated with significantly higher mortality, suggesting
a link between radiation-induced pneumonitis and acute
respiratory failure (9). Azevedo et al. reported that in
multivariate logistic regression, medical admission, active
underlying malignancy newly diagnosed, underlying
malignancy in recurrence or progression, tumor as
reason for ventilatory support, poor performance
status, noninvasive ventilation followed by mechanical
ventilation, only use of IMV, and higher SOFA scores
(each point, excluding the respiratory domain) were
independently associated with hospital mortality (1). In
contrast to a report by Reichner et al. (7) that stage IV nonsmall-cell lung cancer was independently associated with
higher mortality, we found no significant influence on ICU
mortality of the pulmonary and extrapulmonary cancers
and type of pulmonary cancer.
APACHE II score significantly predict ICU mortality
in our patients with cancer. On the other hand, the SAPS
II and APACHE II scores did not significantly predict ICU
mortality in advanced lung cancer. Similar results have
been reported for the SAPS III and APACHE III scores
(8,13,14).
The other variable available at admission and
independently associated with ICU mortality by
multivariate logistic regression was the need for intubation
and mechanical ventilation. Roques et al. (15), Azoulay
et al. (16), and Slatore et al. (17) found that need for
mechanical ventilation was an independent factor for a
worse prognosis in lung cancer.
The present study has important limitations, including
the retrospective nature of the analysis, which may have
resulted in selection bias, and the lack of assessment of
potentially significant predictors of outcome, such as the
role of progression of cancer, airway infiltration, severity
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of comorbid illnesses, complications of cancer therapy,
or performance status in predicting the ICU outcome of
cancer patients. Because the two centers are pulmonary
centers, most of the patients had lung cancer, and for this
reason, our results cannot be generalized for other cancer
types. Moreover, improvements in cancer therapy and ICU
treatment standards may lead to some bias. Prospective,
multicenter trials are necessary to address these issues.
In addition to data on mortality, we need information on
outcomes in survivors after ICU and hospital discharge.
We assessed 1-year survival of patients whose advanced
stage cancer might have had poor prognosis. Postdischarge
survival is strongly dependent on the malignancy type
and its treatment (1). In the present study, females had
poor survival. There was no relationship between sex and
APACHE II score, mechanical ventilation requirement,
and comorbidities. This result may be incidental; we need
further information.
The present data suggest that the medical ICU outcome
of cancer patients is improving but still worse than that of
other critically ill patient populations. We know that ICU
admission is costly, but we did not select patients who
were likely to benefit from ICU admission. In addition, the
patient and family should not be unnecessarily exposed to
the burden associated with an ICU stay. Further studies
concerning patients with cancer admitted to the ICU are
needed to assess long-term mortality, quality of life, ability
to continue chemotherapy, and socioeconomic cost.
In conclusion, the mortality rates of advanced stage
cancer patients who need ICU support are still higher than
overall ICU mortality. High APACHE II scores, female sex,
and need for intubation and mechanical ventilation seem
to be related to mortality in cancer patients who need ICU
support. These predictors must be taken into account for
the survival expectancy of these patients in the ICU.
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